The late-onset Alzheimer’s disease risk factor RHBDF2 is a modifier of microglial TREM2 proteolysis is a research paper published in Life Science Alliance (2025). On theSindex it has a DataRank of 0.318. It has been cited 5 times, with 5 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.269
From this paper's citation signal
Citation Network Contribution
0.0495
From 3 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 5 citers.
Deutsche Forschungsgemeinschaft
Grant: EXC 2145 SyNergy
Centers of Excellence in Neurodegeneration
Grant: CoEN6005
HHS | National Institutes of Health
Grant: R35 GM134907
Deutsche Forschungsgemeinschaft
Grant: unidentified
unidentified
National Institutes of Health
Grant: 5R35GM134907-04
Role of iRhoms and ADAM17 in EGFR and TNFalpha signaling
Friedrich Naumann Stiftung
Alzheimer Forschung Initiative
FWCI
2.09
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals